Novoic

Company specializing in developing a comprehensive speech analytics platform aimed at diagnosing brain diseases through speech therapy. Novoic focuses on creating and validating new algorithms that analyze audio-linguistic patterns in speech, which can be predictive of early stages of neurological diseases like Alzheimer's and Parkinson's, offering a unique approach to early diagnosis. The primary beneficiaries of Novoic's technology are healthcare providers and researchers focused on early detection and intervention of neurological diseases.